328 related articles for article (PubMed ID: 29515971)
1. The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis.
Roufas C; Chasiotis D; Makris A; Efstathiades C; Dimopoulos C; Zaravinos A
Front Oncol; 2018; 8():27. PubMed ID: 29515971
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
[TBL] [Abstract][Full Text] [Related]
3. Distinct genomic features across cytolytic subgroups in skin melanoma.
Roufas C; Georgakopoulos-Soares I; Zaravinos A
Cancer Immunol Immunother; 2021 Nov; 70(11):3137-3154. PubMed ID: 33779796
[TBL] [Abstract][Full Text] [Related]
4. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract][Full Text] [Related]
6. Immune Cytolytic Activity and Strategies for Therapeutic Treatment.
Agioti S; Zaravinos A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612436
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
8. Higher cytolytic score correlates with an immunosuppressive tumor microenvironment and reduced survival in glioblastoma.
Haddad AF; Chen JS; Oh T; Pereira MP; Joshi RS; Aghi MK
Sci Rep; 2020 Oct; 10(1):17580. PubMed ID: 33067480
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Survey of Immune Cytolytic Activity-Associated Gene Co-Expression Networks across 17 Tumor and Normal Tissue Types.
Tian T; Wan J; Han Y; Liu H; Gao F; Pan Y; Song Q; Wei Z
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30181502
[TBL] [Abstract][Full Text] [Related]
10. Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications.
Chen YP; Zhang Y; Lv JW; Li YQ; Wang YQ; He QM; Yang XJ; Sun Y; Mao YP; Yun JP; Liu N; Ma J
Theranostics; 2017; 7(14):3585-3594. PubMed ID: 28912897
[TBL] [Abstract][Full Text] [Related]
11. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
12. Molecular correlates of immune cytolytic subgroups in colorectal cancer by integrated genomics analysis.
Roufas C; Georgakopoulos-Soares I; Zaravinos A
NAR Cancer; 2021 Mar; 3(1):zcab005. PubMed ID: 34316699
[TBL] [Abstract][Full Text] [Related]
13. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
Zhou G; Sprengers D; Mancham S; Erkens R; Boor PPC; van Beek AA; Doukas M; Noordam L; Campos Carrascosa L; de Ruiter V; van Leeuwen RWF; Polak WG; de Jonge J; Groot Koerkamp B; van Rosmalen B; van Gulik TM; Verheij J; IJzermans JNM; Bruno MJ; Kwekkeboom J
J Hepatol; 2019 Oct; 71(4):753-762. PubMed ID: 31195061
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Molecular Characterization of m
Zhu J; Xiao J; Wang M; Hu D
Front Oncol; 2020; 10():618374. PubMed ID: 33585244
[TBL] [Abstract][Full Text] [Related]
15. Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.
Takahashi H; Kawaguchi T; Yan L; Peng X; Qi Q; Morris LGT; Chan TA; Tsung A; Otsuji E; Takabe K
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414098
[TBL] [Abstract][Full Text] [Related]
16. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
Kitsou M; Ayiomamitis GD; Zaravinos A
Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
[TBL] [Abstract][Full Text] [Related]
17. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral expression levels of
Inoue H; Park JH; Kiyotani K; Zewde M; Miyashita A; Jinnin M; Kiniwa Y; Okuyama R; Tanaka R; Fujisawa Y; Kato H; Morita A; Asai J; Katoh N; Yokota K; Akiyama M; Ihn H; Fukushima S; Nakamura Y
Oncoimmunology; 2016; 5(9):e1204507. PubMed ID: 27757299
[TBL] [Abstract][Full Text] [Related]
19. RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.
Bagley SJ; Hwang WT; Brem S; Linette GP; O'Rourke DM; Desai AS
J Neurooncol; 2019 Jan; 141(1):95-102. PubMed ID: 30353265
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma.
Ghatalia P; Gordetsky J; Kuo F; Dulaimi E; Cai KQ; Devarajan K; Bae S; Naik G; Chan TA; Uzzo R; Hakimi AA; Sonpavde G; Plimack E
J Immunother Cancer; 2019 May; 7(1):139. PubMed ID: 31138299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]